LWCA
STJ

Locust Wood Capital Advisers’s St Jude Medical STJ Stock Holding History

Locust Wood Capital Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-114,836
Closed -$9.21M – 49
2016
Q4 		$9.21M Buy
+114,836
New +$9.11M 1.04% 30

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Locust Wood Capital Advisers's STJ Position: Q1 2017 in Review

Locust Wood Capital Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 114,836 shares — an estimated $9.21M sold.

Locust Wood Capital Advisers first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $9.21M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Locust Wood Capital Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Locust Wood Capital Advisers sold 114,836 St Jude Medical shares in Q1 2017, an estimated $9.21M.
  • Locust Wood Capital Advisers first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • Locust Wood Capital Advisers's St Jude Medical position peaked at $9.21M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Locust Wood Capital Advisers's 13F filing for Q1 2017, filed 4 May 2017.